CLINICAL_TRIALS
trial_result
· 2021-06-14
Clinical Trial Update: NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer [Phase 2]
Summary
Phase 2 trial comparing NKTR-102 to irinotecan in second-line, irinotecan-naïve, KRAS-mutant colorectal cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nektar Therapeutics | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-06-14